GxP Compliance for Electronic Records: GLP, GMP, GCP Guide

GxP (Good “x” Practice) is the collective term for quality guidelines and regulations governing life sciences, where “x” represents the specific discipline: GLP (Good Laboratory Practice), GMP (Good Manufacturing Practice), GCP (Good Clinical Practice), GDP (Good Distribution Practice), and GVP (Good Pharmacovigilance Practice). GxP compliance for electronic records requires that data be attributable, immutable, and audit-trailed per ALCOA+ principles, with systems validated under GAMP 5 and electronic signatures meeting FDA 21 CFR Part 11 and EU GMP Annex 11 requirements.

This guide breaks down each GxP discipline, explains how electronic records fit into the regulatory picture, and covers practical best practices for staying compliant.

What Does GxP Mean?

GxP is an abbreviation for “Good x Practice” where “x” is a placeholder for the specific field of practice. These regulations exist to ensure that products in regulated industries are safe, meet their intended use, and follow quality processes throughout their lifecycle. GxP regulations are enforced by agencies including the FDA (United States), EMA (European Union),MHRA (United Kingdom), PMDA (Japan), and TGA (Australia), among others.

The core GxP disciplines relevant to life sciences:

• GLP — Good Laboratory Practice
• GMP — Good Manufacturing Practice
• GCP — Good Clinical Practice
• GDP — Good Distribution Practice
• GVP — Good Pharmacovigilance Practice

Each carries its own requirements for how data is created, maintained, and retained, with specific implications for organizations managing those records electronically.

Breakdown of the GxP Disciplines

Good Laboratory Practice (GLP)

GLP regulations govern non-clinical laboratory studies that support regulatory submissions for pharmaceuticals, pesticides, food additives, cosmetics, and veterinary products. Defined by the OECD Principles of Good Laboratory Practice and enforced by agencies such as the FDA (21 CFR Part 58), GLP ensures the quality, reliability, and integrity of study data.

In a GLP environment, electronic records must capture everything needed to reconstruct a study: raw data, standard operating procedures (SOPs), study plans, and final reports. Any computerized system used in a GLP study must be validated, and data must be attributable, legible, contemporaneous, original, and accurate (the ALCOA principles).

Good Manufacturing Practice (GMP)

GMP covers manufacturing and quality control of pharmaceutical products, active pharmaceutical ingredients (APIs), medical devices, and food products. In the United States, GMP is codified in 21 CFR Parts 210 and 211. The EU equivalent is EudraLex Volume 4, which includes Annex 11 on computerized systems.

GMP electronic records include batch records, equipment logs, deviation reports, CAPA documentation, and environmental monitoring data. Any change to GMP-critical data must be captured in an audit trail that records the original value, the new value, who made the change, when it was made, and why.

Good Clinical Practice (GCP)

GCP is the international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials. The foundational document is ICH E6(R2), which mandates that electronic data in clinical trials be accurate, complete, and verifiable. The FDA's GCP requirements overlap significantly with 21 CFR Part 11.

For organizations running electronic signatures in clinical trials, GCP compliance requires verified signer identity, informed consent records with full audit trails, and the ability to perform source data verification at any point during and after the trial.

Good Distribution Practice (GDP)

GDP regulates the proper distribution of medicinal products for human use across the supply chain. In the EU, GDP is governed by EU Guidelines 2013/C 343/01. These requirements extend to electronic records for temperature monitoring, shipment tracking, returns management, and supplier qualification.

GDP electronic record systems must ensure traceability from manufacturer to patient, including documentation for recalls, transportation conditions, and storage compliance.

Good Pharmacovigilance Practice (GVP)

GVP covers the detection, assessment, understanding, and prevention of adverse drug reactions. Governed primarily by EMA's GVP Modules and the FDA's post-market safety reporting requirements, GVP electronic records include individual case safety reports (ICSRs), periodic safety update reports (PSURs), and risk management plans.

Electronic systems used in pharmacovigilance must support data integrity requirements and enable regulatory submissions in standardized electronic formats such as E2B(R3).

GxP Requirements Comparison

This table shows how GLP, GMP, and GCP differ across key compliance areas:

How Do Electronic Records Fit Into GxP Compliance?

Every GxP discipline requires accurate, complete, and retrievable records. As organizations move from paper to electronic systems, regulatory expectations for those systems go up substantially. Electronic records in a GxP environment must meet several foundational requirements:

1. Data must be attributable. Every action, entry, or modification must be traceable to a specific individual through authenticated user accounts, not shared credentials.
2. Records must be unalterable. Once data is committed, the original record must be preserved. Changes get logged as amendments, not overwrites.
3. Systems must be validated. Before any computerized system is used in a GxP context, it must undergo formal validation to demonstrate it performs as intended.
4. Access must be controlled. Role-based access controls must limit who can create, modify, approve, and view records based on their responsibilities.
5. Audit trails must be immutable. A tamper-evident audit trail must capture every action taken on a record: who, what, when, and why.

EU GMP Annex 11: Requirements for Computerized Systems

Annex 11 to the EU GMP guidelines is the European counterpart to FDA 21 CFR Part 11. It applies to all computerized systems used in GMP-regulated activities. Key requirements:

• Risk management: Organizations must apply a risk-based approach to the lifecycle of computerized systems, assessing the impact on patient safety, product quality, and data integrity.
• Validation: All computerized systems must be validated. Validation depth should be proportional to the system's complexity and risk.
• Data storage and backup: Regular backups must be taken, verified, and stored securely. Data must be recoverable within a defined time period.
• Printouts: It must be possible to produce clear, legible printouts of electronically stored data.
• Audit trail: Annex 11 explicitly requires audit trails for all GMP-relevant changes, and audit trail review must be part of routine data review.
• Electronic signatures: Must carry the same legal impact as handwritten signatures and must be permanently linked to the signed record.

ALCOA+ Data Integrity Principles

ALCOA+ is the gold standard framework for data integrity in GxP environments. Originally developed by the FDA, it's been adopted globally by regulators including the EMA, WHO, and PIC/S:

• Attributable: Who performed the action or acquired the data?
• Legible: Can the data be read and understood throughout its lifecycle?
• Contemporaneous: Was the data recorded at the time the activity was performed?
• Original: Is the data the first capture, or a certified true copy?
• Accurate: Is the data free from errors and does it truthfully reflect the activity?

The “+” extends these with four additional attributes:

• Complete: All data, including repeat or reanalysis data, is present.
• Consistent: Data elements are presented in the expected sequence (e.g., timestamps are chronological).
• Enduring: Data is recorded on permanent media and available throughout the retention period.
• Available: Data is accessible for review and inspection at any time.

System Validation: IQ, OQ, and PQ

Before a computerized system can be used in a GxP environment, it must be formally validated. The GAMP 5 (Good Automated Manufacturing Practice) framework provides the industry-standard approach, typically involving three qualification stages:

Installation Qualification (IQ)

IQ verifies that the system has been installed correctly per the manufacturer's specifications and the organization's requirements: hardware configurations, software versions, network connectivity, and environmental conditions.

Operational Qualification (OQ)

OQ tests that the system operates as intended across its specified operating ranges. This covers user access controls, data entry and retrieval, audit trail functionality, electronic signature workflows, error handling, and integration with other validated systems.

Performance Qualification (PQ)

PQ confirms the system performs reliably under real-world conditions with actual users and data. It runs after IQ and OQ, typically using production data or realistic simulations to demonstrate that the system meets its intended use.

The Role of Audit Trails in GxP Compliance

Audit trails are the single most important technical control in GxP electronic records management. Every regulatory framework, whether 21 CFR Part 11, Annex 11, or ICH E6(R2), requires thorough, immutable audit trails that capture:

• The identity of the user who performed the action
• The date and time of the action (with timezone)
• The specific action taken (create, modify, delete, sign, approve)
• The before and after values for any data modification
• The reason for the change (where applicable)

Audit trails must also be tamper-evident. Any attempt to alter an entry should be detectable. Best-in-class systems use cryptographic hash chains to achieve this; each audit entry is cryptographically linked to the previous one, making undetected tampering computationally infeasible.

Regulatory inspectors increasingly review audit trails during routine inspections. The EMA's guidance on data integrity explicitly states that audit trail review should be a standard part of data governance, not a reactive measure triggered only by deviations.

Training Requirements Across GxP Disciplines

Every GxP regulation requires that personnel be adequately trained for their roles. For electronic records systems, training must cover:

• The regulatory requirements applicable to their work (GLP, GMP, GCP, etc.)
• Proper use of the electronic system, including data entry and retrieval
• The significance and legally binding nature of electronic signatures
• Audit trail awareness and data integrity responsibilities
• Incident reporting procedures for system errors or data integrity concerns

Training must be documented, and records maintained as GxP-critical documentation. Under FDA 21 CFR Part 11, organizations must establish policies that hold individuals accountable for actions taken under their electronic signatures, equivalent to traditional handwritten signatures.

Best Practices for GxP-Compliant Electronic Records

Based on current regulatory guidance and enforcement trends, these practices represent the baseline for maintaining GxP-compliant electronic records:

1. Implement unique user accounts with strong authentication. Shared accounts violate ALCOA+ attributability. Use individual credentials with two-factor authentication for signature events.
2. Enable and review audit trails. Audit trails should be active by default, immutable, and reviewed as part of routine quality processes, not just during deviations.
3. Apply risk-based system validation. Not every system requires the same depth. Use a risk-based approach (per GAMP 5 Category classification) to allocate validation effort proportionally.
4. Maintain controlled access with role-based permissions. Define roles that align with organizational responsibilities, and review access rights periodically.
5. Establish a change control process. Any change to a validated system, whether a configuration update, patch, or upgrade, must go through formal change control with impact assessment.
6. Validate backup and disaster recovery procedures. Data must be recoverable within defined timeframes. Test your recovery procedures regularly.
7. Document everything. SOPs for system use, validation protocols and reports, training records, incident logs, periodic review summaries. All of it.
8. Conduct periodic reviews. GxP compliance isn't a one-time achievement. Schedule regular reviews of system performance, user access, audit trail entries, and training currency.

Choosing the Right Electronic Records Platform

When evaluating platforms for GxP electronic records, look for systems that provide compliance features as built-in capabilities rather than add-ons: immutable audit trails with cryptographic integrity verification, compliant electronic signature workflows with identity verification, role-based access controls, two-factor authentication, and strong security infrastructure.

For a detailed evaluation framework, see our guide on how to choose an e-signature platform for life sciences. If you're working through the differences between EU and US regulatory frameworks for electronic signatures, read our eIDAS vs ESIGN Act comparison.

GxP compliance for electronic records is demanding, but achievable with the right systems, processes, and organizational commitment. The organizations that treat compliance as part of their quality system (not a box-checking exercise) are the ones that consistently pass inspections and protect the integrity of their data.